T1	intervention 12 41	neoadjuvant endocrine therapy
T2	control 57 80	eoadjuvant chemotherapy
T4	total-participants 1086 1089	187
T5	control-participants 1133 1135	95
T6	intervention-participants 1149 1151	92
T7	outcome 1228 1265	complete response or partial response
T8	cv-bin-percent 1299 1304	83.7%
T9	iv-bin-percent 1313 1318	52.9%
T10	outcome 1353 1362	callipers
T11	cv-bin-percent 1368 1373	83.9%
T12	iv-bin-percent 1382 1387	71.3%
T13	outcome 1478 1481	pCR
T14	cv-bin-abs 1418 1423	Three
T15	cv-bin-percent 1438 1442	3.4%
T16	iv-bin-abs 1448 1451	one
T17	iv-bin-percent 1465 1469	1.2%
T18	outcome 1524 1546	conversion rate of BCS
T19	cv-bin-percent 1548 1553	13.8%
T20	iv-bin-percent 1566 1571	11.5%
T21	outcome 1689 1712	grade 3 or worse events
T22	cv-bin-abs 1645 1653	Nineteen
T23	iv-bin-abs 1727 1731	none
T3	outcome-Measure 860 877	clinical response
T24	outcome 1757 1775	clinical responses
